AZN vs MCS · P/E 28, $288.38B cap vs P/E 54, rev $386.1M
AstraZeneca PLC (AZN) versus Marcus Corporation (MCS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Marcus Corporation (MCS) is a entertainment company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported MCS revenue for 2026-06-30 was $386.1M. Net income was $491.0K. MCS currently screens at market cap $733.2M and trailing P/E 54.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. MCS currently screens at market cap $733.2M and trailing P/E 54.2.
Not investment advice. Open the AZN and MCS stock pages for the full models.
Not investment advice.